Read more
3:23 PM · 22 May 2023

Micron fails cybersecurity review in China, shares under pressure📉

Micron Technology (MU.US) shares are losing more than 6% ahead of today's session opening after China's cybersecurity regulator said the company's products failed a cybersecurity review in the country. As reported in Beijing, Micron products sold in China caused security risks to the IT infrastructure of Chinese supply chains. This means that the use of the company's products will be banned from key infrastructure projects in the world's second-largest economy.

The whole affair has to do with the investigation into the security of Micron products launched by the CAC (China Cyberspace Administration) six weeks ago and the ongoing US-China technology war. 

This information alone puts pressure on the company's shares in the short term. Nonetheless, it is worth remembering that the company announced last week that it would invest around 500 billion yen (US$3.6 billion) in technology development in Japan, which may suggest that the company is looking to move its manufacturing centres to other corners of the world.

Map showing all of Micron's research, administration and operations centers. Source: Bloomberg

Micron itself, however, is not as dependent on China as other key US companies. Source: Bloomberg

Micron Technology (MU.US) share price chart, D1 interval. The worrying news from China took the company's shares down to the levels of key support marked by local peaks, which were tested as many as 7 times! Source: xStation 5

7 May 2026, 5:50 PM

Stock of the Week AMD: From second choice to core pillar of the AI infrastructure

7 May 2026, 5:46 PM

US OPEN: Wall Street opens higher 🔼 Datadog and ARM in the spotlight 💥

7 May 2026, 3:51 PM

Rheinmetall earninigs: Weak sales overshadow strong prospects

7 May 2026, 2:45 PM

ARM Holdings Moves Closer to the Center of the AI Revolution. Strong Results Are No Longer Enough for the Market

The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.